Wei (Nancy) Deng is currently the China Development TA Head for General Medicine & Rare Diseases at Amgen, a position they began in 2024. Previously, they served as a Director at Bristol Myers Squibb from 2022 to 2024 and held the role of Associate Director, Clinical Development Rheum Lead at 百时美施贵宝 from 2021 to 2022. Wei has extensive experience in medical science liaison roles at Pfizer and Sanofi from 2017 to 2019, and has worked as a Clinical Research Physician at Eli Lilly and Company from 2019 to 2021. They earned a Master's Degree and MD PhD in Medicine from Nanjing University between 2006 and 2015.
This person is not in the org chart
This person is not in any teams
This person is not in any offices